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Introduction
Hypertension is one of the most common lifestyle-re-
lated diseases and has become one of the most signiﬁ cant 
health problems in recent years (1). Angiotensin-I-con-
verting enzyme (ACE; EC 3.4.15.1) is a circulating enzyme 
that plays an important physiological role in regulating 
blood pressure by converting angiotensin I (inactive form) 
to angiotensin II, which is a potential vasoconstrictor, or 
by inactivating bradykinin, which is a vasodilator (2–5). 
Therefore, inhibition of ACE can be used to suppress 
blood pressure elevation and to treat myocardial infarc-
tion and other cardio-related diseases (2,4).
A negative result of angiotensin II production is the 
formation of intercellular reactive radicals. Free radicals 
are the product of normal aerobic reactions in organisms 
and they play anti-infection roles. However, if their levels 
exceed normal levels, they can cause diseases such as can-
cer, arthritis, atherosclerosis, and diabetes (2). Increased 
concentrations of free radicals in the body can also occur 
via the consumption of oxidant-containing foods (6). Thus, 
neutralizing radicals both in foods and in the body can be 
helpful in the prevention and treatment of diseases.
In recent years, there has been growing interest in 
ﬁ nding safe alternatives to artiﬁ cial antioxidants and syn-
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Summary
Collagen isolated from the ribbon jellyﬁ sh (Chrysaora sp.) was hydrolysed using three 
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tensin-I-converting enzyme (ACE) inhibitory activity and antioxidant activities (i.e. ferric 
reducing antioxidant power (FRAP) and 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical 
scavenging activity) of the peptides were measured and compared, and the eﬀ ect of the 
duration of hydrolysis on the bioactivity (ACE inhibitory and antioxidant activities) of 
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mM) and trypsin-induced hydrolysates (24–26 mM) at 7 and 9 h, respectively. Conversely, 
hydrolysates produced by trypsin for 1 and 3 h showed the highest DPPH radical scaveng-
ing activities (94 and 92 %, respectively). Trypsin-induced hydrolysates (at 3 h) also showed 
the highest ACE inhibitory activity (89 %). The peptide sequences with the highest activi-
ties were identiﬁ ed using tandem mass spectrometry, and the results show that the hydro-
lysates had a high content of hydrophobic amino acids as well as unique amino acid se-
quences, which likely contribute to their biological activities.
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thetic antihypertensive (ACE inhibitor) medicines because 
of their health risks and side eﬀ ects. Biologically active 
peptides have antioxidant and/or antihypertensive activi-
ties and also possess nutritive value; thus they may prove 
to be useful in the pharmaceutical and food industries (7). 
Bioactive peptides have been isolated from diﬀ erent pro-
teins, including soy (8), whey (9), and casein (10), and 
from various marine sources such as ﬁ sh-derived pro-
teins, e.g. sardine, tuna, cod, bonito (3), and waste from 
ﬁ sh processing facilities (2,11). More and more investiga-
tions are being conducted to identify potential sources of 
bioactive peptides (4,6,7). Although collagen peptides are 
assumed to exhibit high antiradical and antihypertensive 
activities due to their high content of hydrophobic amino 
acids (5,6,12), to date few studies have focused on collagen 
or gelatin hydrolysates as a source of these peptides.
Proteolytic hydrolysis of proteins is the most eﬀ ective 
method for the production of bioactive peptides because 
the process releases bioactive fragments that are inactive 
within the protein chain (13). Moreover, by controlling the 
enzymatic hydrolysis process, polypeptides of certain 
sizes can be obtained, and they can be modiﬁ ed to im-
prove their functional properties (6). The characteristics 
and bioactivity of protein hydrolysates depend on many 
factors, including type of protease, enzyme-to-substrate 
ratio, concentration of the substrate, incubation time, tem-
perature, and pH (7). The eﬀ ects of diﬀ erent enzymes (e.g. 
trypsin, alcalase, Protamex, pepsin, and others) and varia-
tions of other parameters have been evaluated in studies 
focused on the preparation and optimization of bioactive 
peptides. However, to identify the optimal conditions for 
isolating bioactive peptides from any individual source, 
the eﬀ ects of diﬀ erent proteases and other conditions 
must be studied individually.
Jellyﬁ sh, which are o en abundant in coastal waters, 
have been used as a food source in Asia, particularly Chi-
na, for more than a thousand years. They have also been 
used for a traditional treatment of diseases such as hyper-
tension, arthritis, gastric ulcer, and many others. The use 
of enzymatic hydrolysates of jellyﬁ sh collagen as antioxi-
dant and/or antihypertensive reagents could add value to 
this underutilized resource, and the hydrosylation pro-
cess could provide a multifunctional ingredient with po-
tential applications in the pharmaceutical, nutraceutical, 
and food and dietary supplement industries.
The ribbon jellyﬁ sh (Chrysaora sp., class Scyphozoa, 
order Semaeostomeae) has recently been found in the 
coastal area around Penang Island, Malaysia, in huge 
blooms. Its bell is about 8–12 cm in diameter, and its ﬂ at 
and ribbon-like oral arms are 20–50 cm long (14). In this 
study we extracted collagen and subsequently produced 
collagen hydrolysates from Chrysaora sp. using three dif-
ferent enzymes (trypsin, alcalase and Protamex). The ACE 
inhibitory and antioxidant activities of the diﬀ erent hydro-
lysates were then measured and compared. Finally, poten-
tial bioactive peptide sequences present in highly bioac-
tive (ACE inhibitor or antioxidant) samples were identiﬁ ed.
Materials and Methods
Materials
Ribbon jellyﬁ sh (Chrysaora sp.) were caught along the 
north coast of Penang Island, Malaysia in March 2011. The 
umbrella was dissected, washed with deionized water, 
and stored at –80 °C until use.
Chemicals and reagents
Pepsin (EC 3.4.23.1, ≥400 U per mg of protein) and tryp-
sin (EC 3.4.21.4) were purchased from Sigma-Aldrich Inc. 
(St. Louis, MO, USA). Alcalase (EC 3.4.21.62) and Protamex™ 
(Bacillus protease complex, EC 3.4.21.62 and 3.4.24.28) 
were supplied by Novozymes A/S (Bagsværd, Denmark). 
SDS-PAGE reagents and molecular mass markers were 
purchased from Bio-Rad Laboratories (Hercules, CA, USA). 
All chemicals and reagents were of analytical grade.
Isolation of collagen
Collagen was extracted according to the method of 
Nagai et al. (15) with slight modiﬁ cation as described by 
Barzideh et al. (16). All procedures were performed at 4 
°C. Jellyﬁ sh umbrellas were thawed at 4 °C for 4–5 h, cut 
into small pieces (0.5 cm×0.5 cm), and washed with dis-
tilled water. To remove non-collagenous substances, each 
sample was treated with 0.1 M NaOH at a sample/solution 
ratio of 1:10 (mass per volume) with gentle stirring for 2 
days; the solution was changed once a day. A er centrifu-
gation at 10 000×g for 30 min, the remaining insoluble mat-
ter was washed with distilled water until neutral pH was 
achieved. It was then suspended in 0.5 M acetic acid (10 
mL of acetic acid for each gram of collagenous material) 
containing 10 % (by mass) pepsin with gentle stirring for 3 
days (digestion process). The ﬁ nal viscous liquid was cen-
trifuged at 20 000×g and 4 °C for 1 h. Digestion of the re-
maining pellet was carried out once more, and the super-
natants were combined. The supernatant was dialysed 
against 10 volumes of 0.02 M Na2HPO4 (pH=8.8) for 3 days 
to inactivate the enzyme. The dialysed sample was centri-
fuged at 20 000×g and 4 °C for 1 h. The resulting precipi-
tate was dissolved in 0.5 M acetic acid and salted out by 
adding NaCl to a ﬁ nal concentration of 1 M, followed by 
centrifugation at 20 000×g and 4 °C for 1 h. The resulting 
precipitate was dissolved in 0.5 M acetic acid and dialysed 
against distilled water for 2 days. The sample, called jel-
lyﬁ sh pepsin-solubilized collagen (JPSC), was lyophilised 
and stored at –80 °C until further analysis.
Preparation of collagen hydrolysates
Samples (100 mg) of the isolated pepsin-solubilised 
collagen (JPSC) were suspended in 100 mL of distilled wa-
ter and digested using one of three diﬀ erent enzymes at 
an enzyme-to-substrate ratio of 1:50 (by mass). Digestion 
was carried out for 9 h at 50 °C, and optimum pH values 
for each enzyme (as suggested by the manufacturer and 
previous research) were as follows: pH=8 for alcalase and 
trypsin, and pH=7 for Protamex (17,18). To evaluate the 
eﬀ ect of the duration of exposure to the enzyme on the 
degree of hydrolysis and bioactivity (ACE inhibitory and 
antioxidant activities) of the peptides, samples were taken 
at 0 (non-hydrolysed collagen), 1, 3, 5, 7, and 9 h. A er 9 h, 
the hydrolytic reaction was terminated by heating the 
samples at 95 °C for 10 min. The samples were then cooled 
to room temperature and centrifuged at 1077×g (3000 rpm) 
for 30 min. The resulting supernatants were lyophilised as 
jellyﬁ sh collagen hydrolysates (JCHs) and stored at –80 °C 
for further analysis.
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Degree of hydrolysis of collagen hydrolysates
The method by Hoyle and Merri  (19) was used to 
determine the degree of hydrolysis (DH) of all the isolated 
JCHs. Trichloroacetic acid (TCA, 20 %) was mixed with an 
equal volume of the hydrolysate solution. TCA-soluble 
materials (10 %) were collected a er centrifugation at 
7000×g for 20 min at 10 °C. The nitrogen content was mea-
sured according to the Kjeldahl method (20). The follow-
ing equation was used to compute the DH:
  
  /1/
Amino acid composition of collagen hydrolysates
To determine the amino acid composition of the ex-
tracted collagen hydrolysates, 0.1 g of the freeze-dried 
JCH samples prepared using all of the enzymes were hy-
drolysed with 6 M HCl (5 mL) at 110 °C for 24 h. Subse-
quently, 400 µL of 50 µmol/mL of -α-amino-n-butyric 
acid (AABA) were added (as the internal standard) to the 
resulting hydrolysates, and distilled deionized water was 
added to reach a volume of 100 mL. Samples were then 
ﬁ ltered through Whatman no. 1 ﬁ lter paper, and then 
through 0.22-µm Millipore ﬁ lter (21). The amino acids of 
the JPSC hydrolysate were derivatised by incubating 10 
µL of the hydrolysed samples with 20 µL of AccQ·FluorTM 
reagent (also known as AQC, and 6-aminoquinolyl-N-hy-
droxysuccinimidyl carbamate) (Waters Corporation, Mil-
ford, MA, USA) for 1 min at room temperature. Samples 
were then placed on the 150-µL glass with polyspring in-
sert (Thermo Scientiﬁ c, San Jose, CA, USA), which was 
equipped with the screw-capped vial, and the vial was 
heated for 10 min at 55 °C before analysis.
The derivatised samples were analysed using a HPLC 
(Waters Corporation). For each sample, a 10-µL aliquot 
was injected into the column, and the solution was eluted 
at a ﬂ ow rate of 1 mL/min. Determination of amino acids 
was carried out according to the AccQ·TagTM method using 
the Waters HPLC system equipped with a Waters 1525 bi-
nary pump, Waters 717 plus autosampler, Waters 2475 
Multi λ ﬂ uorescence detector, and Waters AccQ·TagTM ami-
no acid analysis column (3.9 mm×150 mm; packing mate-
rial: silica-based bonded with C18). The column was ﬁ xed 
at 37 °C with ﬂ uorescence detection at 250 nm for excita-
tion and at 395 nm for emission. AccQ·TagTM eluent A and 
acetonitrile/water (60:40) were used as eluents, and calibra-
tion of the HPLC system was performed using the amino 
acid standard H (Pierce, Rockford, IL, USA) as the refer-
ence. Methionine and cysteine were analysed separately 
using the performic acid procedure described by Moore 
(22). Breeze Workstation v. 3.20 (Waters Corporation) was 
used for data analysis. The area under the peak of each 
amino acid in the chromatogram was calculated and com-
pared with that of the standard. The analysis was carried 
out in triplicate, and the results are reported as per 1000 
amino acid residues.
Antioxidant activity of collagen hydrolysates
Ferric reducing/antioxidant power assay
The ferric ion reducing antioxidant power (FRAP) assay 
was performed according to the method of Benzie and 
Strain (23). It measures the capacity of a sample to reduce 
Fe3+-tripyridyltriazine (TPTZ) to Fe2+-TPTZ (blue colour). 
The FRAP reagent was prepared by combining 10 mM 
TPTZ with 40 mM HCl, 20 mM FeCl3·6H2O and 0.3 M ac-
etate buﬀ er (pH=3.6), at a ratio of 1:1:10.
In this assay, a 2.7-µL sample of JCHs (an aliquot con-
taining 1 mg of JCH in 1 mL of distilled water) was mixed 
with 200 µL of prewarmed FRAP reagent at 37 °C and in-
cubated at 37 °C for 1 h. Absorbance was then measured at 
593 nm using a spectrophotometer (Spectramax M5, Mo-
lecular Devices, Sunnyvale, CA, USA). The antioxidant 
potential of the samples was determined according to a 
standard curve generated using a 0–2 mM solution of 
FeSO4·7H2O. FRAP values were expressed as mM of 
FeSO4·7H2O equivalent per mg of freeze-dried sample.
DPPH free radical scavenging assay
The antioxidant capacity of JPSC and JCHs was deter-
mined using the DPPH radical scavenging assay accord-
ing to the method of Lee et al. (24). An aliquot of 6.66 µL of 
sample (1 mg/mL) was mixed with 200 µL of DPPH re-
agent (0.1 mM in ethanol). The mixture was then mixed 
and incubated at 30 °C for 30 min in the dark. The absor-
bance of the sample was measured at 517 nm using a spec-
trophotometer (Spectramax M5). The control consisted of 
methanol instead of the sample. Gallic acid at concentra-
tions ranging from 0 to 60 µg/mL was used as the stan-
dard. The results are expressed as percentage of inhibition 
of DPPH radicals using the following equation:
 DPPH=((Acontrol−Asample)/Acontrol)·100 /2/
where Asample is the absorbance of the samples at diﬀ erent 
times and Acontrol is the absorbance of DPPH solution with-
out the sample.
Evaluation of ACE inhibitory activity of collagen 
hydrolysates
The ACE inhibitory activity was measured according 
to the method of Cushman and Cheung (25) with modiﬁ -
cations. For this analysis, a sample (50 µL at a concentra-
tion of 1 mg/mL) was mixed with 50 µL of ACE solution 
(50 mU/mL in sodium borate buﬀ er, pH=8.3) and incu-
bated at 37 °C for 10 min. Next, 150 µL of hippuryl-histi-
dyl-leucine (4.15 mM in borate buﬀ er containing 0.3 M 
NaCl, pH=8.3) were added to the standard reaction mix-
ture and incubated at 37 °C for 30 min. The reaction was 
stopped by adding 500 µL of 1 M HCl. To extract the re-
sulting hippuric acid, 1.5 mL of ethyl acetate were added 
and the mixture was vortexed for 1 min. A er resting for 5 
min, 800 µL of the ethyl acetate layer were removed and 
vacuum dried in a vacuum concentrator (Concentrator 
5301, Eppendorf, Hamburg, Germany) at 45 °C for 30 min. 
The dried sample was dissolved in 1 mL of distilled water, 
and the absorbance was measured at 228 nm using a spec-
trophotometer (Spectramax M5). Positive and negative 
controls consisted of 50 µL of 1 M HCl and 50 µL of dis-
tilled water, respectively, instead of the sample. The ACE 
inhibitory activity was calculated using the equation:
 ACE inhibition=((Anegative−Asample)/Anegative)·100 /3/
where Anegative is the absorbance of the negative control, 
and Asample is the absorbance of the sample at diﬀ erent 
times. The absorbance of the positive control was used as 
the reading correction.
DH
nitrogen soluble in 10 % TCA
total nitrogen in the sampl
=
e





⋅100
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Identiﬁ cation of bioactive peptides extracted from 
collagen hydrolysates
To identify the bioactive peptides in the JCHs, the 
peptides with the highest DPPH radical scavenging activ-
ity, FRAP reducing activity, and ACE inhibitory activity 
were subjected to peptide sequencing using mass spec-
trometry. A 200-µL aliquot containing 2 mg/mL of JCH in 
distilled water was ﬁ ltered through a syringe ﬁ lter (2 µm, 
Amicon, Merck Millipore, Carrigtwohill, County Cork, 
Ireland). Mass spectroscopy of the sample was then con-
ducted using a Thermo LTQ/Orbitrap Velos coupled with 
an EASY-nLC II system (Thermo Scientiﬁ c).
Chromatographic separation of peptides was per-
formed using an EASY-Column C18-A2 (100 mm×0.075 
mm i.d., particle size 3 µm) coupled with a precolumn 
(EASY-Column, 200 mm×0.1 mm i.d., particle size 5 µm) 
(both from Thermo Scientiﬁ c) at a ﬂ ow rate of 0.3 µL/min; 
the injection volume of the sample was 10 µL. The precol-
umn was equilibrated for 15 µL at a ﬂ ow rate of 3 µL/min, 
while the analytical column was equilibrated for 4 µL at a 
ﬂ ow rate of 0.3 µL/min. Running buﬀ ers were used as fol-
lows: deionized distilled water with 0.1 % formic acid (A), 
and acetonitrile with 0.1 % formic acid (B). The pump gra-
dient elution of nano-LC was as follows: 0–70 min, 5–45 % 
B; 70–85 min, 45–100 % B; and 85–100 min, 100 % B.
The eluent was sprayed into the mass spectrometer at 
2.3 kV (source voltage), and a capillary temperature of 200 
°C was used. Peptides were detected by full scan mass 
analysis from m/z=200–2000 at resolving power of 60 000 
(at m/z=400, full width at half maximum (FWHM); 1-s ac-
quisition) with data-dependent MS/MS analyses (ion trap 
mass spectrometry, ITMS) triggered by the eight most 
abundant ions from the parent mass list of predicted pep-
tides with the rejection of single or unassigned charge 
state. The ITMS analysis was performed using the same 
resolving power (60 000), and collision-induced dissocia-
tion (CID) was conducted with isolation width of 2 Da, 
normalized collision energy of 35, activation q of 0.25, ac-
tivation time of 50 ms, and charge state of 2 or higher.
Data acquisition was performed using Xcalibur v. 2.1 
(Thermo Scientiﬁ c) with a mass tolerance threshold of 5 
ppm. Data analysis was performed using PEAKS studio v. 
6.0 (Bioinformatic Solutions Inc., Waterloo, Canada) and 
Peptide Ranker (ShieldsLab, Dublin, Ireland).
Statistical analysis
All experiments were performed at least in triplicate, 
and data are presented as mean±standard deviation. 
Analysis of variance (ANOVA) was performed and com-
parisons of the mean values were conducted using Dun-
can’s multiple range tests. Diﬀ erences were considered 
signiﬁ cant at the probability value of p<0.05. Analysis was 
performed using SPSS v. 20 for Mac OS (IBM, Armonk, 
NY, USA).
Results and Discussion
Degree of hydrolysis
Degree of hydrolysis (DH) is an important parameter 
when monitoring the hydrolysis process and comparing 
diﬀ erent protein hydrolysates in terms of peptide length, 
functional and sensory properties, and nutritional value 
(6,11). DH is directly correlated with the solubility of the 
protein hydrolysates, which is increased through diges-
tion of the parent protein (11).
Fig. 1 shows the DH of the JCHs digested using the 
three enzymes over the course of the incubation period. 
The hydrolysis of all enzymes was fast during the initial 
stage of the process (3–5 h), but then the rate of hydrolysis 
gradually decreased until it reached a stationary phase, 
during which no apparent hydrolysis took place. This re-
sult, which shows that most peptides were cleaved within 
the ﬁ rst 3–5 h of hydrolysis, is in agreement with the clas-
sic protease-induced hydrolysis reported for other pro-
teins (26). However, there is a diﬀ erence between the pat-
terns of hydrolysis using Protamex and the other two 
enzymes. Increase of DH was biphasic when using trypsin 
and alcalase, while it was monophasic when using Prota-
mex. It has been suggested that the activity of alcalase and 
trypsin starts with hydrolysing some reachable sites (up 
to 3 h of hydrolysis, phase 1). A er cleavage of the ﬁ rst 
susceptible bonds and deformation of the polypeptide 
chain, new susceptible bonds become exposed to the en-
zyme. Therefore, cleavage goes fast again for another 
phase (up to 5 h, phase 2) before reaching a stationary 
phase (biphasic hydrolysis). However, with Protamex, 
which is a mixture of two enzymes and is specialized in 
cleaving the peptide bonds at certain sites, cleavage of all 
target bonds occurs simultaneously. Therefore, the hydro-
lysis trend using Protamex is monophasic.
During the ﬁ rst 3 h of hydrolysis, exposure of JPSC to 
Protamex resulted in the highest DH (37 %); values for al-
calase and trypsin were 30 and 25 %, respectively. How-
ever, a er 9 h of hydrolysis, the highest DH was found in 
the JCH produced by alcalase (48 %), followed by Prota-
mex (43 %) and trypsin (36 %). This result is in agreement 
with other studies that reported alcalase to be more eﬃ  -
cient than trypsin (26). In our experiment, the parent pro-
tein was identical in all three treatments, and hydrolysis 
conditions were optimized for each enzyme. Thus, the dif-
ference in DH among treatments might be due to the abil-
ity of the diﬀ erent enzymes to cleave certain hydrolysable 
bonds (6).
DH is an important factor aﬀ ecting the bioactivity of 
protein hydrolysates because it inﬂ uences the size of pep-
tides and the exposure of certain amino acids or functional 
Fig. 1. Enzymatic hydrolysis of jellyﬁ sh collagen using trypsin, 
alcalase, and Protamex. DH=degree of hydrolysis
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groups at the peptide terminals (26). Therefore, to evalu-
ate the eﬀ ect of DH on the bioactivity (ACE inhibitory and 
antioxidant activities) of hydrolysates, all assays were car-
ried out on JCHs digested using the three diﬀ erent en-
zymes at every hour of hydrolysis.
Amino acid content
Table 1 shows the amino acid composition of the JCHs 
expressed per 1000 amino acid residues. The amino acid 
composition of all JCH samples hydrolysed by three en-
zymes was similar, and also similar to that of jellyﬁ sh col-
lagen (16) and to the typical proﬁ le of collagen, with Gly 
as the most abundant amino acid (32 %) (26) and with 
Hyp present.
The amino acid proﬁ le revealed that amino acids 
mainly consisted of hydrophobic residues. Wan Mohtar et 
al. (27) reported that the presence of a considerable quan-
tity of hydrophobic amino acids in peptide sequences con-
tributes to ACE inhibitory activity and antioxidant activi-
ty in several bioactive peptides. Among the hydrophobic 
amino acids, Gly was dominant with 319 residues. Ala 
and Pro were the next most abundant hydrophobic amino 
acids, with 91 and 73 residues, respectively, followed by 
Leu, Ile, Val, Phe, Met, and Tyr. The JCHs also contained a 
high amount of the non-hydrophobic amino acids Asp (69 
residues) and Glu (82 residues), which have been reported 
to exhibit high antioxidant activity due to the donation of 
electrons to free radicals (13,28).
Pro plays an important role in ACE inhibitory and an-
tioxidant activities (27,29). The presence of Tyr, Trp, Met, 
Lys (2,13,28), Pro, Leu, and Asp has also been reported to 
contribute to the antioxidant activity (29), and a high con-
tent of Gly, Pro, Ala, Glu, and Asp has been found in many 
other ACE inhibitory peptides (13). Therefore, the amino 
acid composition of the JCHs indicates that they have an-
tioxidant and/or ACE inhibitory properties. 
Antioxidant activity
Antioxidant activity of proteins and peptides is not 
a ributed to a single mechanism because proteins contain 
various amino acids with diﬀ erent antioxidant properties. 
Some antioxidant components are more eﬀ ective in metal 
chelating, whereas some others are radical scavengers or 
lipid peroxidation inhibitors (26,30). Thus, diﬀ erent anti-
oxidant assays are required to evaluate the antioxidant 
capacity of protein hydrolysates, and none of them can 
individually be referred to as a standard method. In this 
study, FRAP and DPPH radical scavenging assays were 
applied to investigate the antioxidant activity of the JCHs.
Results of FRAP assay
The ability of the sample to reduce the ferric ion is an 
indicator of potential antioxidant activity. In this process, 
the free radical is neutralized by receiving an electron do-
nated by the reducing agent (i.e. the sample) and subse-
quently by acquiring a hydrogen from its environment 
solution (6). In this assay, the result of the reduction of fer-
ric (Fe3+) to ferrous (Fe+2) ion in the FRAP reagent is the 
formation of Fe2+-TPTZ, which is a blue-coloured complex 
with the highest absorbance at 593 nm (30).
Fig. 2 shows the ferric reducing capacity of non-hy-
drolysed JPSC and the JCHs. The JCH samples had higher 
values than the non-hydrolysed collagen, probably due to 
the release of protons and electrons (hydrogen ions) dur-
ing hydrolysis (31). The ability of all three JCHs to scav-
enge ferric ion increased as incubation time increased, 
with the highest activity at 7 and 9 h, with no signiﬁ cant 
diﬀ erence for each individual JCH (p>0.05). Among the 
three enzymes tested, digestion with Protamex and tryp-
sin resulted in the highest FRAP activities, which might be 
due to the release of peptides with certain sequences as 
well as exposure of some amino acid residues (Tyr, Lys, 
and Met) and side chains that exhibit higher antioxidant 
activity (6,13).
The correlation between the DH and reducing capac-
ity is not always clear. For example, the alcalase-induced 
hydrolysate with the highest DH had the lowest reducing 
power, and the reducing power of the Protamex-induced 
hydrolysate and the trypsin-induced hydrolysate did not 
diﬀ er signiﬁ cantly even though the former had a higher 
DH than the la er. This might be due to the position of 
speciﬁ c amino acids within the peptide sequences that 
confer antioxidant activity to the puriﬁ ed peptide (29).
Results of DPPH free radical scavenging activity assay
DPPH is an organic nitrogen radical. The percentage 
of DPPH radical inhibition by the sample within a certain 
period of time is an indicator of the antioxidant capacity of 
the sample (13). JPSC and JCHs obtained using diﬀ erent 
enzymes for various periods of incubation were evaluated 
Table 1. Amino acid composition of jellyﬁ sh collagen hydroly-
sates (JCHs) per 1000 residues
Amino acid JCH
Hyp   39
Asp   69
Ser   60
Glu   82
Gly 319
His ND
Arg   42
Thr   44
Ala   91
Pro   73
Cys ND
Tyr   14
Val   27
Met   20
Lys   23
Ile   31
Leu   43
Phe   23
Total 10000
Total hydrophobic* 641
*Hydrophobic amino acids: Leu, Ile, Phe, Ala, Val, Tyr, Met, Gly, Pro.
ND=not detected
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for their radical scavenging activity. Although DPPH radi-
cal scavenging activity was observed in both non-hy-
drolysed collagen and collagen hydrolysates, the la er 
showed higher values (Fig. 3). This result shows that en-
zymatic hydrolysis improved the antioxidant activity via 
the release of low molecular mass peptides and by in-
creasing the exposure of hydrogen-donating amino acids 
(13,30).
For all of the JHCs, the highest value of DPPH scav-
enging activity was observed within the ﬁ rst 1 to 3 h of 
hydrolysis, with no signiﬁ cant diﬀ erences among enzyme 
treatments (p<0.05). However, as the duration of hydroly-
sis increased, DPPH scavenging activity decreased. This 
result emphasizes the premise that the size of the peptide 
plays an important role in the bioactivity of the peptide. 
Excess hydrolysis might have a reverse eﬀ ect by produc-
ing very short peptides or free amino acids that do not 
exhibit radical scavenging activity (13).
The DPPH scavenging activity of the trypsin-induced 
JCH was more than two times higher than that of the non- 
-hydrolysed collagen, and the values of Protamex and al-
calase were following the trypsin-induced one. Several 
factors, including amino acid composition, DH, peptide 
size, peptide sequence, and type of the applied enzyme, 
can inﬂ uence the antioxidant capacity of the collagen hy-
drolysate. For the JCHs in this study, the parent protein 
used in all treatments was the same, so the observed dif-
ferences cannot be due to amino acid composition; how-
ever, they might be due to various amino acid sequences 
within the peptides (particularly at N- and C-terminals) or 
various peptide lengths (2).
ACE inhibitory activity of collagen hydrolysates
The JCHs were subjected to the ACE inhibitory activ-
ity assay to identify the hydrolysates with the highest ac-
tivities. All sample types, including the non-hydrolysed 
collagen, showed ACE inhibition activity to some extent, 
but treatment with the three enzymes resulted in signiﬁ -
cantly increased ACE inhibitory activity (Fig. 4). There-
fore, enzymatic hydrolysis seems essential to cleave the 
Fig. 2. Results of the FRAP assay for hydrolysates produced using: a) trypsin, b) alcalase and c) Protamex. Diﬀ erent le ers (a, b, c 
and d) in each graph (within the same hydrolysate) indicate signiﬁ cant diﬀ erences (p<0.05). Data are the mean values±standard de-
viation from at least three repetitions
Fig. 3. Results of the DPPH scavenging assay for hydrolysates produced using: a) trypsin, b) alcalase and c) Protamex. Diﬀ erent let-
ters (a, b, c, d and e) in each graph (within the same hydrolysate) indicate signiﬁ cant diﬀ erences (p<0.05). Data are the mean 
values±standard deviation from at least three repetitions
Fig. 4. Results of the ACE inhibitory activity assay for hydrolysates produced using: a) trypsin, b) alcalase and c) Protamex. Diﬀ erent 
le ers (a, b, c, d and e) in each graph (within the same hydrolysate) indicate signiﬁ cant diﬀ erences (p<0.05). Data are the mean 
values±standard deviation from at least three repetitions
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collagen and release ACE inhibitory peptides. The observed 
bioactivity (ACE inhibitory and antioxidant activities) of 
non-hydrolysed collagen might be due to partial hydroly-
sis of collagen during the process of suspending the col-
lagen in water.
A direct correlation between the incubation time and 
ACE inhibition activity was observed only up to 3 h in 
case of all enzymes; a er 3 h the activity decreased. This 
result again emphasizes the important role of peptide size 
in deﬁ ning its bioactivity. However, diﬀ erent enzymes 
with almost the same DH did not show the same ACE in-
hibitory potency. For example, the hydrolysates produced 
by exposure to alcalase for 1 h and trypsin for 3 h had 
similar DH values (26 and 25 %, respectively), but diﬀ er-
ent ACE inhibitory values (59 and 89 %, respectively). The 
hydrolysates generated by incubation with trypsin for 5 h 
and Protamex for 1 h both had 33 % DH, but their ACE 
inhibitory values were 34 and 51 %, respectively. On the 
other hand, some of the peptides with diﬀ erent DH (hy-
drolysed by diﬀ erent enzymes) showed similar ACE in-
hibitory activities. For example, the hydrolysates pro-
duced by exposure to alcalase for 1 h (59 % DH) and 
Protamex for 3 h (26 % DH) had similar ACE inhibitory 
values. These observations suggest that instead of the size 
of the peptide or the DH, the amino acid sequence of the 
collagen hydrolysates might be important element in de-
termining the bioactivity of a peptide (3).
The trypsin-induced hydrolysates showed the high-
est ACE inhibitory activity, followed by alcalase and Pro-
tamex. In studies of marine protein sources and corn glu-
ten (7,32,33), Protamex was reported to be more eﬀ ective 
than alcalase, whereas Alemán et al. (26) found that they 
were equally eﬀ ective. In some studies, trypsin was more 
eﬀ ective in producing ACE inhibitors than alcalase (3), 
but in other cases alcalase was more eﬀ ective (18,34). 
These diﬀ erent actions of the same enzyme on diﬀ erent 
substrates or diﬀ erent enzymes on the same substrate (as 
in our study) indicate that along with DH and other pa-
rameters, the protein sequence of the substrate or the ef-
fectiveness of a protease on a certain substrate (i.e. sub-
strate speciﬁ city) is a very important factor (7). Therefore, 
it is crucial to select an appropriate protease to produce 
speciﬁ c bioactive peptide sequences, and this choice de-
pends on the raw material proteins and the expected bio-
activity.
Potential bioactive peptides from collagen hydrolysates
A er identifying the samples with the highest bioac-
tivity (FRAP, DPPH and ACE inhibition), the relevant hy-
drolysates were analysed to determine their amino acid 
sequence. Using mass spectroscopy and PEAKS studio 
so ware v. 6.0, peptide sequences present in the samples 
were identiﬁ ed. Next, by applying the results to Peptide- 
Ranker so ware (screening of peptides with the certainty 
of more than 50 %) (35), peptide sequences that may have 
high antioxidant and ACE inhibitory were identiﬁ ed (Ta-
ble 2).
All of these peptides contain 7 to 16 amino acid resi-
dues, which is the reported range for bioactive peptides 
(2–20 residues) (36). The molecular mass of these peptides 
ranged from 677 to 1351 Da. Many of the ACE inhibitory 
peptides have been reported to be shorter than 1500 Da 
(18). Low molecular mass peptides are able to pass 
through the intestine and be absorbed easily (29), which 
makes these peptides useful as an ingredient in functional 
foods.
In all of the peptide sequences, the majority of amino 
acid residues are hydrophobic. He et al. (32) suggested 
that a high quantity of hydrophobic amino acids (branched 
side chain or aromatic), such as Pro, Glu, Val, Phe and Tyr, 
particularly at the C-terminal end of the peptide, enhances 
the ACE inhibitory capacity of the hydrolysate (32). There-
fore, the high ACE inhibitory activity of separated hydro-
lysates might lie in the high content of these amino acids 
in the peptide sequence. However, as Li et al. (37) suggest-
ed, the presence of hydrophilic amino acids within the 
peptide sequence at certain intervals between hydropho-
bic amino acids plays an important role in ACE inhibitory 
activity too.
It has been reported that the presence of repeating di- 
or tripeptides within the peptide sequence enhances the 
bioactivity of the peptide as compared to the same indi-
vidual amino acids (13). In our study, the presence of re-
peating amino acids, such as Ala-Ala, Pro-Pro and Leu- 
-Leu, was observed within the identiﬁ ed peptide sequences.
In addition, the identiﬁ ed peptides contain shorter 
fragments (i.e. certain dipeptides, tripeptides, etc.) such as 
Leu-Gly, Gly-Pro, Gly-Pro-Ala, Leu-Gly-Pro-Val and many 
others within their sequence, which have been conﬁ rmed 
as ACE inhibitors and/or antioxidants (29,38). In order to 
Table 2. Identiﬁ cation of peptide sequences with the highest bioactivity from three diﬀ erent hydrolysates
Trypsin 1 h Trypsin 3 h Protamex 9 h
Peptide sequence   Mr/Da Score* Peptide sequence   Mr/Da Score Peptide sequence   Mr/Da Score
GCGLGDPPGHGK 1093.498  0.82 ALGPSGAAGPAGPDGR 1349.669  0.67 WGPGPPGDLGAA 1093.519  0.84
AAGPAGPDGR   867.420  0.74 LGPVGDCKGPPK 1166.612  0.64 DPGAGPPGDLGAA 1093.504  0.76
LGPVMMLGHGR 1166.605  0.70 GSLGPVGDPGGSVGR 1310.658  0.64 VPVPGPL   677.411  0.70
ALGPSGAAGPAGDPGR 1349.669  0.70 GSLGPVGDPGQVGR 1294.663  0.58 LEGPPGPY   828.402  0.53
LGPVGDCKGPPK 1166.612  0.64 SLGPVGDPGQVGR 1237.641  0.52
GPQGPAGELGEQGR 1351.648  0.58 LGPVGDPGQVGR 1150.609  0.51
GSLGPVGDPGQVGR 1294.663  0.54 ALGPSGAAQPGPDGR 1349.669  0.50
MGAGLLGHK   882.475  0.51
*The score was obtained from PeptideRanker (35)
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ﬁ nd these short peptides, the identiﬁ ed bioactive peptides 
were investigated using two bioactive peptide databases, 
BIOPEP (39) and EROP-Moscow (40). Some of the identi-
ﬁ ed subsequences are summarized in Table 3. However, it 
should be considered that this study provides only some 
of the potential bioactive subsequences and there might 
be more unknown components that play an important 
role in exhibiting ACE inhibitory and antioxidant activi-
ties of the isolated peptides.
Many factors concurrently aﬀ ect the bioactivity of 
peptides, and it is not easy to identify the best peptide 
from one type of protein to compare with similar peptides 
from other proteins. Although the amino acid sequence of 
a bioactive peptide is an important parameter in confer-
ring high bioactivity (ACE inhibitory and antioxidant ac-
tivities), amino acid composition and the sequence of the 
rest of the peptides, which depend on the parent protein, 
can be important parameters as well, and there is an as-
sumption that the presence of some other fractions can 
have a synergistic eﬀ ect on the bioactivity of the detected 
bioactive ones (4). In addition, other factors such as con-
centration of the hydrolysate, pH, and temperature can be 
the reasons for diﬀ erences in reports about same proteins.
Conclusion
The ACE inhibitory activity and antioxidant activity 
of jellyﬁ sh collagen hydrolysates obtained using three dif-
ferent enzymes were studied. The isolated peptides showed 
considerable antioxidant and ACE inhibitory activities. 
Therefore, this underutilized resource may prove useful 
as a food additive, ingredient for functional foods, and nu-
Table 3. Bioactive subsequences within the identiﬁ ed potentially bioactive peptides from three diﬀ erent hydrolysates
Bioactive
fragment Peptide Bioactivity
GP AAGPAGPDGR, LGPVMMLGHGR, ALGPSGAAGPAGDPGR LGPVGDCKGPPK, 
GPQGPAGELG, GSLGPVGDPGQVGR ALGPSGAAGPAGPDGR, LGPVGDCKGPPK, 
WGPGPPGDLGAA, GSLGPVGDPGGSVGR, VPVPGPL GSLGPVGDPGQVGR, LEGPPGPY, 
DPGAGPPGDLGAA, SLGPVGDPGQVGR, LGPVGDPG, ALGPSGAAQPGPDGR 
ACE inhibitory1,2 
Antioxidant activity1
GL GCGLGDPPGHGK, MGAGLLGHK ACE inhibitory1,2 
Antioxidant activity1
GK GCGLGDPPGHGK ACE inhibitory1,2 
Antioxidant activity1
AA ALGPSGAAGPAGDPGR, AAGPAGPDGR, ALGPSGAAGPAGPDGR, DPGAGPPGDLGAA, 
ALGPSGAAQPGPDGR, WGPGPPGDLGAA 
ACE inhibitory1,2 
Antioxidant activity1,2
GH GCGLGDPPGHGK, LGPVMMLGHGR, MGAGLLGHK ACE inhibitory1,2 
Antioxidant activity1
GR GPQGPAGELGEQGR, GSLGPVGDPGQVGR, AAGPAGPDGR LGPVMMLGHGR, 
ALGPSGAAGPAGDPGR GSLGPVGDPGGSVGR, LGPVGDPGQVGR, GSLGPVGDPGQVGR, 
SLGPVGDPGQVGR, ALGPSGAAQPGPDGR, ALGPSGAAGPAGPDGR
ACE inhibitory1,2 
HG GCGLGDPPGHGK, LGPVMMLGHGR ACE inhibitory1,2 
Antioxidant activity1
GD GCGLGDPPGHGK, ALGPSGAAGPAGDPGR, QVGRLGPVGDCKGPPK, GSLGPVGDPGQVGR, 
WGPGPPGDLGAA
LGPVGDCKGPPK, DPGAGPPGDLGAA, SLGPVGDPGQVGR GSLGPVGDPGGSVGR, 
GSLGPVGDPGQVGR, LGPVGDPG 
ACE inhibitory1 
Antioxidant activity1
PV GSLGPVGDPGQVGR, LGPVGDCKGPPK, LGPVMMLGHGR, LGPVGDCKGPPK, 
GSLGPVGDPGGSVGR, VPVPGPLSLGPVGDPGQVGR, LGPVGDPGQVGR 
ACE inhibitory1,2 
Antioxidant activity1
LG GCGLGDPPGHGK, LGPVMMLGHGR, ALGPSGAAGPAGDPGR, SLGPVGDPGQVGR, 
LGPVGDCKGPPK, GPQGPAGELG, GSLGPVGDPGQVGR, LGPVGDPG MGAGLLGHK, 
ALGPSGAAGPAGPDGR, LGPVGDCKGPPK DPGAGPPGDLGAA, WGPGPPGDLGAA 
ALGPSGAAQPGPDGR, GSLGPVGDPGGSVGR, GSLGPVGDPGQVGR, 
ACE inhibitory1,2 
Antioxidant activity1
PG ALGPSGAAGPAGDPGR, GSLGPVGDPGGSVGR, LEGPPGPY GSLGPVGDPGQVGR, 
SLGPVGDPGQVGR, LGPVGDPG GSLGPVGDPGQVGR, ALGPSGAAQPGPDGR, 
VPVPGPL GCGLGDPPGHGK, WGPGPPGDLGAA, DPGAGPPGDLGAA 
ACE inhibitory1,2 
Antioxidant activity1
PP LGPVGDCKGPPK, WGPGPPGDLGAA, DPGAGPPGDLGAA LEGPPGPY ACE inhibitory1,2 
Antioxidant activity1,2
GPA GPQGPAGELGEQGR, ALGPSGAAGPAGDPGR AAGPAGPDGR, ALGPSGAAGPAGPDGR ACE inhibitory1 
Antioxidant activity1
LGPV GSLGPVGDPGQVGR, LGPVGDCKGPPK, LGPVMMLGHGR LGPVGDCKGPPK, 
GSLGPVGDPGGSVGR LGPVGDPGQVGR, GSLGPVGDPGQVGR SLGPVGDPGQVGR 
ACE inhibitory1 
GDP GSLGPVGDPGQVGR, ALGPSGAAGPAGDPGR GCGLGDPPGHGK, GSLGPVGDPGGSVGR 
GSLGPVGDPGQVGR, SLGPVGDPGQVGR LGPVGDPGQVGR 
Antioxidant activity1
1BIOPEP database (39)
2EROP-Moscow database (40)
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traceutical and pharmaceutical agent. The results of this 
study also suggest that exposure to diﬀ erent proteases and 
diﬀ erent degrees of hydrolysis aﬀ ects the bioactivity po-
tency of the hydrolysate from the same parent protein.
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